• BioArctic will receive SEK 203.8 million in royalties for the third quarter of 2026, up approximately 74% year over year.
• Preliminary global Leqembi sales from partner Eisai totaled JPY 32.2 billion for the period.
• Third-quarter results are due November 25, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioArctic AB published the original content used to generate this news brief via Cision (Ref. ID: 202610280600BITN____UKPR__SV_20261028-BIT-1087-0) on October 28, 2026, and is solely responsible for the information contained therein.